Teva Pharmaceutical Industries (BSP:T1EV34) E10: R$-8.25 (As of Mar. 2026)


BSP:T1EV34 Teva Pharmaceutical Industries Ltd BSP:T1EV34
11 GF Score
Price R$89.28
GF Value R$53.01
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Teva Pharmaceutical Industries E10?

Teva Pharmaceutical Industries BSP:T1EV34 +3.83% 11 E10 is R$-8.25 as of Mar. 2026. GuruFocus rates BSP:T1EV34 with a GF Score™ of 11/100 and a GF Value™ of R$53.01 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Teva Pharmaceutical Industries's adjusted earnings per share data for the three months ended in Mar. 2026 was R$0.811. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$-8.25 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -16.70% per year. During the past 5 years, the average E10 Growth Rate was -26.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Teva Pharmaceutical Industries was 32.10% per year. The lowest was -105.30% per year. And the median was 15.50% per year.

As of today (2026-07-03), Teva Pharmaceutical Industries's current stock price is R$89.28. Teva Pharmaceutical Industries's E10 for the quarter that ended in Mar. 2026 was R$-8.25. Teva Pharmaceutical Industries's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Teva Pharmaceutical Industries was 365.53. The lowest was 8.42. And the median was 33.39.


Teva Pharmaceutical Industries  (BSP:T1EV34) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Teva Pharmaceutical Industries was 365.53. The lowest was 8.42. And the median was 33.39.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Teva Pharmaceutical Industries E10 Related Terms


Teva Pharmaceutical Industries E10 Historical Data

* Premium members only.

The historical data trend for Teva Pharmaceutical Industries's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teva Pharmaceutical Industries E10 Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.63 -4.46 -4.74 -7.84 -8.21

Teva Pharmaceutical Industries Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.52 -7.97 -7.63 -8.21 -8.25

BSP:T1EV34 vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Shiller PE Ratio falls into.


BSP:T1EV34
11GF Score
Teva Pharmaceutical Industries Ltd BSP:T1EV34
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teva Pharmaceutical Industries E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Teva Pharmaceutical Industries's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.811/330.2130*330.2130
=0.811

Current CPI (Mar. 2026) = 330.2130.

Teva Pharmaceutical Industries Quarterly Data

per share eps CPI Adj_EPS
201606 0.342 241.018 0.469
201609 0.569 241.428 0.778
201612 -1.861 241.432 -2.545
201703 0.891 243.801 1.207
201706 -9.787 244.955 -13.193
201709 0.814 246.819 1.089
201712 -18.798 246.524 -25.179
201803 1.689 249.554 2.235
201806 -0.453 251.989 -0.594
201809 -0.555 252.439 -0.726
201812 -5.534 251.233 -7.274
201903 -0.192 254.202 -0.249
201906 -1.215 256.143 -1.566
201909 -0.597 256.759 -0.768
201912 0.205 256.974 0.263
202003 0.147 258.115 0.188
202006 0.337 257.797 0.432
202009 -10.719 260.280 -13.599
202012 0.360 260.474 0.456
202103 0.197 264.877 0.246
202106 0.478 271.696 0.581
202109 0.686 274.310 0.826
202112 -0.396 278.802 -0.469
202203 -2.140 287.504 -2.458
202206 -0.530 296.311 -0.591
202209 0.131 296.808 0.146
202212 -2.885 296.797 -3.210
202303 -0.521 301.836 -0.570
202306 -1.893 305.109 -2.049
202309 0.148 307.789 0.159
202312 1.004 306.746 1.081
202403 -0.299 312.332 -0.316
202406 -2.020 314.175 -2.123
202409 -1.080 315.301 -1.131
202412 -0.580 315.605 -0.607
202503 0.518 319.799 0.535
202506 0.665 322.561 0.681
202509 0.992 324.800 1.009
202512 1.118 324.054 1.139
202603 0.811 330.213 0.811

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of R$-8.25 mean?
Teva Pharmaceutical Industries (BSP:T1EV34) has a E10 of R$-8.25 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Teva Pharmaceutical Industries and its competitors.
Is Teva Pharmaceutical Industries' E10 too high?
Teva Pharmaceutical Industries' current E10 is R$-8.25. Overall, Teva Pharmaceutical Industries has a GF Score™ of 11/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Teva Pharmaceutical Industries' E10 compare to ZTS and UTHR?
Teva Pharmaceutical Industries' E10 of R$-8.25 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Teva Pharmaceutical Industries and its competitors. Teva Pharmaceutical Industries's current E10 is R$-8.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teva Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Teva Pharmaceutical Industries (BSP:T1EV34) is currently considered Significantly Overvalued. The stock's GF Value™ is R$53.01, compared to a current price of R$89.28 — trading 68.4% above its estimated fair value. The current E10 is R$-8.25. Teva Pharmaceutical Industries' overall GF Score™ is 11/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Teva Pharmaceutical Industries (BSP:T1EV34), the current E10 is R$-8.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teva Pharmaceutical Industries (BSP:T1EV34) Overvalued in 2026?

Based on GuruFocus' analysis, Teva Pharmaceutical Industries stock appears to be overvalued. The current stock price of R$89.28 is trading 68.4% above its estimated GF Value™ of R$53.01. GuruFocus considers Teva Pharmaceutical Industries to be Significantly Overvalued.

Key valuation signals for BSP:T1EV34:

  • E10: R$-8.25
  • GF Value™: R$53.01 vs. price of R$89.28 (68.4% above fair value)
  • GF Score™: 11/100 with 5 warning signs

No single metric tells the full story. See the BSP:T1EV34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Teva Pharmaceutical Industries Business Description

Address 124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
11GF Score

Get the complete analysis for BSP:T1EV34

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$89.28
Price
R$53.01
GF Value